Peter Ghali, MD, M.Sc. - Peter Ghali, MD, M.Sc. - Research Institute MUHC
liver disease • transplantation
My research focuses on liver diseases and the outcomes of liver transplant. My main interests are in hepatitis C virus and fatty liver disease. I am interested in how these diseases affect non-transplanted and transplanted people and in therapies.
Bhat M, Ghali P, Rollet-Kurhajec KC, Bhat A, Wong P, Deschenes M, Sebastiani G. Serum fibrosis biomarkers predict death and graft loss in liver transplant recipients. Liver Transpl. 2015 Jul 20. doi: 10.1002/lt.24217. [Epub ahead of print] PMID: 26194602.
Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, Deschenes M, Ghali P. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis. PLoS One. 2015 Jun 17;10(6):e0128774. doi: 10.1371/journal.pone.0128774. eCollection 2015. PMID: 26083565.
Chen T, Wong R, Wong P, Rollet-Kurhajec KC, Alshaalan R, Deschenes M, Ghali P, Sebastiani G. Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity. Liver Int. 2015 Feb 9. doi: 10.1111/liv.12802. [Epub ahead of print] PMID: 25676459.
Sebastiani G, Ghali P, Wong P, Klein MB, Deschenes M, Myers RP. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol. 2014 Jan;28(1):23-30. PMID: 24416739.
Antar R, Wong P, Ghali P. A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol. 2012 Jul;26(7):463-7. PMID: 22803023.